DTL
BLCM

Dynamic Technology Lab’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Dynamic Technology Lab’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,794
Closed -$110K – 1406
2018
Q3 		$110K Buy
+1,794
New +$121K 0.02% 945
2018
Q2 		– Sell
-2,586
Closed -$170K – 1406
2018
Q1 		$170K Buy
+2,586
New +$195K 0.03% 922
2017
Q2 		– Sell
-2,245
Closed -$277K – 1403
2017
Q1 		$277K Buy
+2,245
New +$294K 0.07% 631

Other funds holding BLCM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's BLCM Position: Q4 2018 in Review

Dynamic Technology Lab sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2018, closing a stake of 1,794 shares — an estimated $110K sold.

Dynamic Technology Lab first reported a position in BLCM in Q1 2017 and held it in 3 quarters. The position peaked at $277K in Q1 2017. 92 funds tracked by Wall St. Rank hold BLCM as of Q4 2018.

  • Dynamic Technology Lab reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,794 Bellicum Pharmaceuticals, Inc. shares in Q4 2018, an estimated $110K.
  • Dynamic Technology Lab first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2017 and held it in 3 quarters.
  • Dynamic Technology Lab's Bellicum Pharmaceuticals, Inc. position peaked at $277K in Q1 2017.
  • 92 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2018.

Based on Dynamic Technology Lab's 13F filing for Q4 2018, filed 13 Feb 2019.